Summary & Overview

HCPCS Level II Q4278: Epieffect, Per Square Centimeter

HCPCS Level II code Q4278 designates Epieffect billed per square centimeter as an add-on supply or service to be reported in addition to a primary procedure. This area-based code matters nationally because it standardizes reporting for products applied by surface area, enabling consistent billing when clinicians use Epieffect in conjunction with primary wound care, dermatologic, or minor surgical procedures. Clear reporting supports proper claims adjudication and enables aggregation of utilization data for policy and coverage decisions.

Key payers discussed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for area-based topical treatments, the service settings where Q4278 is typically used, and which payers are commonly relevant to coverage and claims processing. The publication also summarizes what to expect from billing practice: add-on reporting requirements, common modifiers (listed elsewhere), and implications for claim submission and reimbursement workflows.

The report provides national-level benchmarks where available, outlines recent policy updates affecting HCPCS add-on codes, and situates Q4278 within related billing categories for topical and wound-care products. Data not available in the input is noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareQ4278HCPCS Level IIadd-on codetopical treatmentwound caredermal productper square centimeterbilling guidanceoutpatient procedure

Billing Code Overview

HCPCS Level II code Q4278 describes Epieffect, per square centimeter and is billed as an add-on (list separately in addition to the primary procedure). This code represents a topical or surface-applied biologic or device product measured and billed by area treated.

Service type: Topical/dermal treatment applied per square centimeter

Typical site of service: Outpatient procedural settings or clinic-based wound/dermal treatment areas

Clinical & Coding Specifications

Clinical Context

A 58-year-old patient with a chronic non-healing surgical wound on the lower leg presents to a wound care clinic for adjunctive topical therapy. The treating clinician elects to apply a topical enzyme-based product, billed as Q4278 (Epieffect, per square centimeter) as an add-on to the primary wound debridement and dressing procedures. The clinical workflow includes wound assessment, measurement of wound area in square centimeters, wound cleansing and debridement (sharp or enzymatic as appropriate), application of Q4278 to the measured wound bed per manufacturer instructions, and placement of an appropriate dressing. Documentation includes wound dimensions, percent of wound treated with the product, indication for use (e.g., to assist in removal of necrotic tissue or biofilm management), amount of product used in square centimeters, date/time of application, and the primary procedure(s) to which this add-on product is linked. Typical sites of service are outpatient wound care clinics, hospital outpatient departments, long-term care facilities, and home health visits where topical adjunctive wound therapies are provided.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier used; standard reporting	Use when no special modifier applies and reporting the add-on product with the primary procedure.
`22`	Increased procedural services	Use when there is significantly greater work, time, or complexity associated with the primary procedure to which `Q4278` is an adjunct.
`23`	Unusual anesthesia	Use when general anesthesia is required for the primary procedure in otherwise non-anesthesia cases.
`52`	Reduced services	Use when the primary procedure is partially reduced or not performed to the full extent yet `Q4278` is still applied to the treated area.
`53`	Discontinued procedure	Use when the primary procedure is started but discontinued and `Q4278` was applied before discontinuation.
`54`	Surgical care only	Use when the billing clinician provided only the surgical component and `Q4278` is billed by the surgeon as adjunctive product.
`55`	Postoperative management only	Use when the clinician providing postoperative care bills for services and documents application of `Q4278` in the postoperative period.
`62`	Two surgeons	Use when two surgeons work together and billing reflects shared responsibility for the primary procedure and adjunct product application.
`78`	Unplanned return to OR	Use when the patient returns to the operating room for related treatment and `Q4278` is applied on the return procedure.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery	Use when an advanced practice clinician serves as an assistant and documentation supports their role relative to the primary procedure and adjunct application.
`FX`	Peer-to-peer review indicator (carrier-specific)	Use when required by a payer in relation to utilization review or payment issues for the product.
`QX`	Attachments (modifier for reporting assistant at surgery)	Use when a certified registered nurse anesthetist or other specified practitioner supports the primary procedure and payer requires the modifier.
`QY`	Medical direction of two, three, or four certified registered nurse anesthetists by a physician	Use when physician medical direction is documented and payer policy requires this modifier for related anesthesia services.
`SH`	Physician/other qualified health care professional services provided under a shared/split E/M	Use when split/shared services are billed for the evaluation and management components surrounding the procedure and product application.

Taxonomy Code	Specialty	Notes
`174500000X`	General Surgery	Surgeons performing debridement and managing complex wounds commonly order adjunctive topical products.
`263V00000X`	Wound Care/Pain Management	Clinicians specialized in wound care (physicians or nurse practitioners) frequently manage topical adjuncts like `Q4278`.
`207Q00000X`	Family Medicine	Primary care providers in outpatient settings or home health physicians may apply or authorize topical adjuncts as part of wound management.
`363A00000X`	Nurse Practitioner	NPs in wound clinics or home health settings often perform assessment and application of topical wound products.
`163W00000X`	Physical Medicine & Rehabilitation	PM&R specialists involved in complex wound rehabilitation programs may use adjunct topical therapies as part of multidisciplinary care.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`L97.309`	Non-pressure chronic ulcer of unspecified part of lower leg with unspecified severity	Common indication for topical enzymatic products applied per square centimeter to assist debridement and wound bed preparation.
`L98.4`	Chronic ulcer of skin, not elsewhere classified	Frequently used for chronic, non-healing ulcers where adjunctive topical therapies like `Q4278` may be applied.
`S81.811A`	Open wound, right lower leg, initial encounter	Acute open wounds sometimes receive topical enzymatic agents as adjunctive therapy when necrotic tissue is present.
`T81.31XA`	Disruption of external operation (postprocedural) wound, not elsewhere classified, initial encounter	Postoperative wound complications with necrosis or dehiscence may prompt use of topical enzymatic products billed with `Q4278`.
`E11.621`	Type 2 diabetes mellitus with foot ulcer	Diabetic foot ulcers often require adjunctive topical treatments and meticulous documentation of area treated in square centimeters.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`11042`	Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less	Often performed before applying `Q4278` to remove necrotic tissue and prepare the wound bed; primary procedure to which the add-on product is linked.
`11044`	Debridement, muscle and/or fascia (includes epidermis, dermis, subcutaneous tissue, and fascia, if performed); first 20 sq cm or less	Used for deeper wound debridement when indicated prior to application of topical adjuncts such as `Q4278`.
`97597`	Debridement (eg, high pressure waterjet, sharp, enzymatic), selective debridement, without anesthesia, initial 20 sq cm or less	Common outpatient debridement code used alongside topical enzymatic products; documents the debridement service preceding `Q4278` application.
`97602`	Negative pressure wound therapy (NPWT), initial placement	May be used after application of adjunct topical product when NPWT is indicated for wound management; part of the overall wound care plan.
`15271`	Application of skin substitute graft to trunk, arms, legs; first 100 sq cm or less, single or split-thickness	For wounds requiring grafting, `Q4278` may be used earlier in the treatment course; grafting codes represent subsequent reconstructive steps.